Novartis ships cell-culture flu vaccines; WHO recommends trivalent flu vax strain switch for 2015;

> Novartis ($NVS) has shipped its cell-culture flu vaccines for the 2014-2015 season. Report

> The World Health Organization (WHO) recommends switching two of the three strains in 2015 trivalent vaccines. More

> The FDA has granted MabVax's neuroblastoma vaccine candidate its orphan drug designation. Release

> Dr. Jon Andrus will join the Sabin Vaccine Institute as EVP and director of vaccine advocacy and education. Release

And Finally... Novartis' vaccine facility in North Carolina is a possible second site to make experimental Ebola drug ZMapp. Report

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.